Advertisement

Prevention

  • Marta Díaz-MenéndezEmail author
  • Clara Crespillo-Andújar
Chapter
Part of the SpringerBriefs in Immunology book series (BRIEFSIMMUN)

Abstract

Prevention of infectious diseases is centrepiece for control and reduction of new cases during an outbreak. In the case of mosquito born disease, to which ZIKV belongs, prevention must be made in a transversal, multidisciplinary and simultaneously net of actions and controls. In this chapter we will approach to prevention from the different points of view. For the mosquito control, an environmental management can be carried out in order to reduce natural and artificial water containers used by the mosquito for the ovoposition, larval hatchery and mosquito live cycle. Insecticides and Biological (predators, parasites or biological competitors) or Genetic control (with technics of mosquito population reduction or replacement) can be used in order to reduce mosquito and larvae population. From another point of view, personal protection from mosquito-bite with physical barriers and repellent is essential to reduce the number of infected people and, at the same time, the mosquito source of infection. On the other hand, we will review international advice on prevention for the different mechanisms of ZIKV infection and finally a summary of the most relevant international guidelines for a better knowing and management ZIKV infection are presented.

Keywords

Insecticide Resistance Mosquito Population Personal Protection ZIKV Infection Vector Control Intervention 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Yasuoka J, Levins R, Mangione TW, Spielman A (2006) Community-based rice ecosystem management for suppressing vector anophelines in Sri Lanka. Trans R Soc Trop Med Hyg 100(11):995–1006CrossRefPubMedGoogle Scholar
  2. 2.
    World Health Organization technical report series. Environmental management for vector control. Report of the who expert committee on Vector Biology and Control Enviromental management for vector control. Environment International. 1980. http://apps.who.int/iris/bitstream/10665/41404/1/WHO_TRS_649.pdf. Accessed 28 Feb 2017
  3. 3.
    Becker N, Petric D, Zgomba M, Boase C, Minoo M, Dahl C et al (2010) Mosquitoes and Their Control. Springer Science & Business MediaGoogle Scholar
  4. 4.
    World Health Organization (2016) Vector control operations framework for Zika Virus. http://apps.who.int/iris/bitstream/10665/207481/1/WHO_ZIKV_VC_16.4_eng.pdf?ua=1. Accessed 1 Mar 2017
  5. 5.
    Vezzani D (2007) Review: artificial container-breeding mosquitoes and cemeteries: a perfect match. Trop Med Int Health 12(2):299–313CrossRefPubMedGoogle Scholar
  6. 6.
    United Nations Environmental Program (2001) Stockholm Convention on persistent organic pollutants. New York. http://www.pops.int/documents/convtext/convtext_en.pdf. Accessed 2 Feb 2017
  7. 7.
    The use of DDT in Malaria control, WHO position statement. World Health Organization. http://apps.who.int/iris/bitstream/10665/69945/1/WHO_HTM_GMP_2011_eng.pdf. Accessed 15 Mar 2017
  8. 8.
    Use of Malathion for vector control. Report of a WHO meeting in Geneva 16–17 May 2016. In WHO Pesticide Evaluation Scheme. World Health Organization. http://apps.who.int/iris/bitstream/10665/207475/1/9789241510578_eng.pdf?ua=1. Accessed 10 Feb 2017
  9. 9.
    Pesticides and their application for the control of vector and pest of public health important, WHO guidelines 2006. In WHO Pesticide Evaluation Scheme. World Health Organization. http://apps.who.int/iris/bitstream/10665/69795/1/WHO_CDS_NTD_WHOPES_GCDPP_2006.1_eng.pdf. Accessed 15 Feb 2017
  10. 10.
    Monitoring and managing insecticide resistance in Aedes mosquito population. Interim guidance for entomologists. In: Emergencies preparedness. 2016. World Health Organization. http://apps.who.int/iris/bitstream/10665/204588/2/WHO_ZIKV_VC_16.1_eng.pdf?ua=1. Accessed 15 Feb 2017
  11. 11.
    Wanjala CL, Mbugi JP, Ototo E et al (2015) Pyrethroid and DDT resistance and organophosphate susceptibility among Anopheles spp. Mosquitoes, Western Kenya. Emerg Infect Dis 21(12):2178–2181CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Marcombe S, Mathieu RB, Pocquet N, Riaz M-A, Poupardin R, Sélior S et al (2012) Insecticide resistance in the dengue vector Aedes aegypti from Martinique: distribution, mechanisms and relations with environmental factors. PLoS ONE 7(2):e30989CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Brogdon WG, Chan A (2017) Guideline for evaluating insecticide resistance in vectors using CDC bottle bioassay. Centers for Disease Control and Prevention. https://www.cdc.gov/malaria/resources/pdf/fsp/ir_manual/ir_cdc_bioassay_en.pdf. Accessed 20 Mar 2017
  14. 14.
    Protecting the health and safety of workers in emergency vector control of Aedes mosquitoes. Interim guidance for vector control and health workers. World Health Organization. http://apps.who.int/iris/bitstream/10665/204612/1/WHO_ZIKV_VC_16.3_eng.pdf. Accessed 20 Mar 2017
  15. 15.
    Werren JH, Baldo L, Clark ME (2008) Wolbachia: master manipulators of invertebrate biology. Nat Rev Microbiol 6(10):741–751CrossRefPubMedGoogle Scholar
  16. 16.
    Zug R, Hammerstein P (2015) Bad guys turned nice? A critical assessment of Wolbachia mutualisms in arthropod hosts. Biol Rev Camb Philos Soc 90(1):89–111CrossRefPubMedGoogle Scholar
  17. 17.
    Dutra HLC, Rocha MN, Dias FBS, Mansur SB, Caragata EP, Moreira LA (2016) Wolbachia blocks currently circulating Zika virus isolates in brazilian Aedes aegypti mosquitoes. Cell Host Microbe 19(6):771–774CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Chen LH, Hochberg NS, Magill AJ (2015) Chapter 2: The pre-travel consultation. Counseling & advice for travelers. Centers for Disease Control and Prevention. CDC Yellow Book. https://wwwnc.cdc.gov/travel/yellowbook/2016/the-pre-travel-consultation/the-pre-travel-consultation. Accessed: 10 Mar 2017
  19. 19.
    Health worker roles in providing safe abortion care and post-abortion contraception. In Sexual and reproductive health. July 2015. World Health Organization. http://www.who.int/reproductivehealth/publications/unsafe_abortion/abortion-task-shifting/en/ Accessed 15 Feb 2017
  20. 20.
    Safe abortion: technical and policy guidance for health systems. In Sexual and reproductive health. June 2015. World Health Organization. http://www.who.int/reproductivehealth/publications/unsafe_abortion/9789241548434/en/ Accessed 15 Feb 2017
  21. 21.
    Medical eligibility criteria for contraceptive use. Fifth edition. In Sexual and reproductive health. August 2015. World Health Organization. http://www.who.int/reproductivehealth/publications/family_planning/MEC-5/en/. Accessed 13 Mar 2017
  22. 22.
    World Health Organization: Vector control operations framework for Zika virus (2016) http://apps.who.int/iris/bitstream/10665/207481/1/WHO_ZIKV_VC_16.4_eng.pdf. Accessed 28 Feb 2017
  23. 23.
    Infant feeding in areas of Zika virus transmission. Summary of rapid advice. WHO guidelines. June 2016. World Health Organization. http://apps.who.int/iris/bitstream/10665/204473/1/WHO_ZIKV_MOC_16.5_eng.pdf. Accessed 20 Feb 2017
  24. 24.
    Pregnancy management in the context of Zika virus infection. In Emergencies preparedness response. 13 May 2016. World Health Organization. http://www.who.int/csr/resources/publications/zika/pregnancy-management/en/. Accessed 15 Mar 2017
  25. 25.
    Healthcare Exposure to Zika and Infection Control (2016) Centers for Disease Control and Prevention. https://www.cdc.gov/zika/hc-providers/infection-control.html. Accessed: 21 Mar 2017
  26. 26.
    Musso D, Nhan T, Robin E, Roche C, Bierlaire D, Zisou K et al (2014) Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014, Euro Surveill 19Google Scholar
  27. 27.
    WHO guidelines: Maintaining a safe and adequate blood supply during Zika virus outbreaks Interim guidance. February 2016. World Health Organization. http://www.who.int/csr/resources/publications/zika/safe-blood/en/. Accessed 15 Feb 2017
  28. 28.
    FDA guideline: Donor Screening Recommendations to Reduce the Risk of Transmission of Zika Virus by Human Cells, Tissues, and Cellular and Tissue-Based Products. March 2016. Food and Drug administration. https://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Tissue/UCM488582.pdf. Accessed 15 Feb 2017

Copyright information

© The Author(s) 2017

Authors and Affiliations

  • Marta Díaz-Menéndez
    • 1
    Email author
  • Clara Crespillo-Andújar
    • 1
  1. 1.Tropical Medicine DepartmentHospital Universitario La Paz-Carlos IIIMadridSpain

Personalised recommendations